Connect with us

Science

U.S. FDA advisory panel votes in favor of Johnson & Johnson’s Covid-19 vaccine

A panel of expert advisers to the U.S. Food and Drug Administration on Feb. 26 voted in favor of authorizing Johnson & Johnson’s Covid-19 vaccine for emergency use, bringing it an important step closer to a U.S. rollout.

Avatar

Published

on

U.S. FDA advisory panel votes in favor of Johnson & Johnson’s COVID-19 vaccine

(Reuters) – A panel of expert advisers to the U.S. Food and Drug Administration (FDA) on Friday voted in favor of authorizing Johnson & Johnson’s COVID-19 vaccine for emergency use, bringing it an important step closer to a U.S. rollout.

The FDA is likely to authorize the one-shot vaccine within a day or so after receiving the recommendation of the panel, making it the third available in the United States.

 

Reporting by Manas Mishra in Bengaluru; editing by Peter Henderson

FILE PHOTO: Vials labelled “COVID-19 Coronavirus Vaccine” and sryinge are seen in front of displayed Johnson&Johnson logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo

 

Reuters source:

https://www.reuters.com/article/us-health-coronavirus-johnson-johnson-fd/u-s-fda-advisory-panel-votes-in-favor-of-johnson-johnsons-covid-19-vaccine-idUSKBN2AQ316

 

Read More

Continue Reading
Advertisement